Elisa Moraga

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in Spain.

Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in Spain.

Journal: EClinicalMedicine

Published: March 11, 2026

Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells.

Fingolimod increases cellular resistance to HIV-1 infection and limits viral reservoir size in peripheral CD4+ T-cells.

Journal: PLoS pathogens

Published: December 19, 2025

Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size.

Identification of Inflammation Markers as Novel Potential Predictors of the HIV-DNA Reservoir Size.

Journal: International journal of molecular sciences

Published: July 15, 2025

Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial).

Bictegravir/emtricitabine/tenofovir alafenamide for primary HIV infection: Efficacy, safety and impact on viral reservoir (the BIC-PHI clinical trial).

Journal: The Journal of infection

Published: May 19, 2025

Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size.

Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size.

Journal: Scientific reports

Published: February 24, 2025

HIV-Tat upregulates the expression of senescence biomarkers in CD4+ T-cells.

HIV-Tat upregulates the expression of senescence biomarkers in CD4+ T-cells.

Journal: Frontiers in immunology

Published: January 30, 2025

Maca (Lepidium meyenii Walp.) inhibits HIV-1 infection through the activity of thiadiazole alkaloids in viral integration.

Maca (Lepidium meyenii Walp.) inhibits HIV-1 infection through the activity of thiadiazole alkaloids in viral integration.

Journal: Journal of ethnopharmacology

Published: June 07, 2024

Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients.

Expansion of CD56dimCD16neg NK Cell Subset and Increased Inhibitory KIRs in Hospitalized COVID-19 Patients.

Journal: Viruses

Published: November 18, 2021

Showing 1-8 of 8

Last Updated: 09/26/2026